Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bicycle Therapeutics (BCYC) Shares Outstanding (2018 - 2025)

Bicycle Therapeutics' Shares Outstanding history spans 8 years, with the latest figure at $69.4 million for Q4 2025.

  • For Q4 2025, Shares Outstanding changed 0.44% year-over-year to $69.4 million; the TTM value through Dec 2025 reached $69.4 million, changed 0.44%, while the annual FY2025 figure was $69.4 million, 0.44% changed from the prior year.
  • Shares Outstanding reached $69.4 million in Q4 2025 per BCYC's latest filing, roughly flat from $69.3 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $69.4 million in Q4 2025 to a low of $23.5 million in Q1 2021.
  • Average Shares Outstanding over 5 years is $44.7 million, with a median of $36.5 million recorded in 2023.
  • Peak YoY movement for Shares Outstanding: skyrocketed 125.4% in 2024, then rose 0.42% in 2025.
  • A 5-year view of Shares Outstanding shows it stood at $29.6 million in 2021, then increased by 1.0% to $29.9 million in 2022, then skyrocketed by 42.04% to $42.4 million in 2023, then surged by 62.76% to $69.1 million in 2024, then rose by 0.44% to $69.4 million in 2025.
  • Per Business Quant, the three most recent readings for BCYC's Shares Outstanding are $69.4 million (Q4 2025), $69.3 million (Q3 2025), and $69.3 million (Q2 2025).